Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novartis (Rights for Cibacen and Cibadrex)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of rights of two pharmaceutical drugs. The drugs mainly used for the treatment of hypertension.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Acquirer
Primary Office
  • P.O. Box CH - 4002
  • Basel
  • Switzerland

Novartis (Rights for Cibacen and Cibadrex) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novartis (Rights for Cibacen and Cibadrex)‘s full profile, request access.

Request full access to PitchBook

Novartis (Rights for Cibacen and Cibadrex) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Novartis (Rights for Cibacen and Cibadrex)‘s full profile, request access.

Request full access to PitchBook